[Ad hoc announcement pursuant to Art. 53 LR] Roche records
Basel, 18 October 2022 Group sales up 2%1 at constant exchange rates (CER) and 1% in Swiss francs; as expected, significantly lower COVID-19-related...
Source: globenewswire.com
Page 10 - Diagnostics Division News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Diagnostics Division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Diagnostics Division Today - Breaking & Trending Today
![[Ad hoc announcement pursuant to Art. 53 LR] Roche records solid results for the first nine months of 2022 - Vimarsana News](https://www.marketscreener.com/images/twitter_MS_fdnoir.png)
[Ad hoc announcement pursuant to Art. 53 LR] Roche records solid results for the first nine months of 2022
Basel, 18 October 2022 Group sales up 2%1 at constant exchange rates and 1% in Swiss francs; as expected, significantly lower COVID-19-related sales in both divisions in the third quarterSales... | October 18, 2022
Source: marketscreener.com
Roche 9-month Sales Up 2%; Confirms 2022 Outlook
SOUTH SAN FRANCISCO (dpa-AFX) - Roche reported that, in the first nine months, the Group generated sales growth of 2%, or 1% in francs, year-over-year to 47 billion Swiss francs. Sales of the Pharmaceuticals
Source: finanznachrichten.de
F. Hoffmann-La Roche Ltd: [Ad hoc announcement pursuant to Art. 53 LR] Roche records solid results for the first nine months of 2022
Basel, 18 October 2022 Group sales up 2%1 at constant exchange rates (CER) and 1% in Swiss francs; as expected, significantly lower COVID-19-related sales in both divisions in the third quarterSales
Source: finanznachrichten.de
Global Clinical Microbiology Instruments and Reagents Market Report 2022: Advancements in Molecular Diagnostics Drive Growth
/PRNewswire/ -- The "Clinical Microbiology Instruments and Reagents - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's...
Source: prnewswire.com